32
https://pubmed.ncbi.nlm.nih.gov/38115859
The abstract reports the increasing antimicrobial resistance in Neisseria gonorrhoeae in Bangkok, Thailand from 2015-2021, with a continuous high susceptibility to ceftriaxone, but increasing MICs of ceftriaxone, cefixime, and azithromycin, posing a significant threat as they are the last remaining options for gonorrhoea treatment.